Can naloxone be used to treat dextromethorphan poisoning and what is the dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naloxone for Dextromethorphan Poisoning

Naloxone can be used to treat dextromethorphan poisoning with respiratory depression, with a recommended dose of 0.04-0.4 mg IV/IM initially, titrating up to 2 mg as needed and repeating every 2-3 minutes until respiratory function improves. 1, 2

Mechanism and Efficacy

  • Naloxone has shown effectiveness in antagonizing dextromethorphan toxicity, particularly when respiratory depression is present 3
  • While dextromethorphan is not an opioid, it has structural similarities to opioids that may explain naloxone's effectiveness in certain cases
  • Naloxone is most effective for the respiratory depression component of dextromethorphan poisoning rather than all toxic effects

Dosing Guidelines

  • Initial dose:
    • Adults: 0.2-2 mg IV/IO/IM 1
    • Children: 0.1 mg/kg IV/IO/IM 1
    • Intranasal: 2-4 mg 1
  • Titrate to reversal of respiratory depression and restoration of protective airway reflexes
  • Repeat every 2-3 minutes as needed if inadequate response 1, 2
  • For opioid-dependent patients, use lower initial doses (0.04-0.4 mg) to avoid precipitating severe withdrawal 2

Clinical Decision Algorithm

  1. Assessment: Evaluate for signs of dextromethorphan toxicity:

    • Respiratory depression (primary target for naloxone therapy)
    • Altered mental status/sedation
    • Mydriasis (dilated pupils)
    • Tachycardia, hypertension
    • Potential serotonin syndrome with higher doses
  2. Treatment approach:

    • For patients with respiratory depression: Administer naloxone as per dosing guidelines above
    • For patients without respiratory depression but with other symptoms: Naloxone may be less effective; focus on supportive care
  3. Monitoring after naloxone administration:

    • Monitor for at least 2 hours after the last naloxone dose 2
    • Be prepared to administer additional doses as naloxone's duration (30-45 minutes) may be shorter than dextromethorphan's effects 2

Important Considerations

  • Naloxone should be considered for dextromethorphan overdose patients who are sedated or comatose, particularly those with respiratory depression 4

  • For severe dextromethorphan poisoning with serotonin syndrome, additional treatments may be needed:

    • Benzodiazepines for seizures
    • External cooling for hyperthermia (>104°F/40°C) 4
    • Consider activated charcoal if presentation is within 1 hour of ingestion 4
  • Patients who have ingested >7.5 mg/kg of dextromethorphan should be referred to an emergency department regardless of symptoms 4

Limitations and Caveats

  • While naloxone has been reported effective in some cases of dextromethorphan poisoning 3, response may be variable
  • Naloxone will not address all aspects of dextromethorphan toxicity, particularly serotonergic effects
  • For severe cases with serotonin syndrome, additional treatments like benzodiazepines and supportive care are essential 5
  • Patients should be monitored closely as naloxone's duration of action is shorter than many drugs, including dextromethorphan 2
  • All patients with intentional abuse or suicidal intent should be referred to an emergency department regardless of symptoms 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Overdose Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.